by Katie Honeywood | Mar 4, 2026 | Uncategorized
New Research Exploring FAK Inhibitors to Prevent Osteosarcoma Lung Metastasis Researchers are exploring a new strategy to stop osteosarcoma from spreading to the lungs, one of the biggest challenges in treating this aggressive bone cancer. A team at Colorado...
by Katie Honeywood | Jan 8, 2026 | Uncategorized
In March 2025, we sadly lost the founder of the Osteosarcoma Now. His close personal connection to osteosarcoma led them to support the development of Osteosarcoma Now by funding the creation of the website and database. The work itself was carried out by a dedicated...
by Katie Honeywood | Nov 25, 2025 | Uncategorized
We are delighted to share an important milestone in osteosarcoma research and in the journey of The Bardo Foundation. A new scientific paper, co-funded by the Bardo Foundation with the Myrovlytis Trust, has been published. It marks the first-ever published paper from...
by Katie Honeywood | Oct 29, 2025 | Uncategorized
Scientists at Johns Hopkins Medicine have uncovered an unexpected link between the nervous system and bone cancer growth. Their new study suggests that the nerves which carry pain signals might also be helping osteosarcoma tumours grow and spread. Osteosarcoma is the...
by Katie Honeywood | Sep 9, 2025 | Uncategorized
Mifamurtide after Surgery in Osteosarcoma: Who Might Benefit? A new analysis from Italy and Spain looked at almost 400 people (ages 4–40) with non-metastatic high-grade osteosarcoma of the arms or legs. It suggests that adding mifamurtide after surgery may help...
by Katie Honeywood | Jul 8, 2025 | Uncategorized
We are excited to announce that Osteosarcoma Now has transitioned to ownership under The Bardo Foundation. This change represents a significant opportunity for advancement, while preserving the mission and core values that unite our community. We extend sincere...
